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Abstract
Genome-wide yeast two-hybrid (Y2H) screens were conducted to elucidate the molecular functions of open reading frames
(ORFs) encoded by murine c-herpesvirus 68 (MHV-68). A library of 84 MHV-68 genes and gene fragments was generated in a
Gateway entry plasmid and transferred to Y2H vectors. All possible pair-wise interactions between viral proteins were tested
in the Y2H assay, resulting in the identification of 23 intra-viral protein-protein interactions (PPIs). Seventy percent of the
interactions between viral proteins were confirmed by co-immunoprecipitation experiments. To systematically investigate
virus-cellular protein interactions, the MHV-68 Y2H constructs were screened against a cellular cDNA library, yielding 243
viral-cellular PPIs involving 197 distinct cellar proteins. Network analyses indicated that cellular proteins targeted by MHV-68
had more partners in the cellular PPI network and were located closer to each other than expected by chance. Taking
advantage of this observation, we scored the cellular proteins based on their network distances from other MHV-68-
interacting proteins and segregated them into high (Y2H-HP) and low priority/not-scored (Y2H-LP/NS) groups. Significantly
more genes from Y2H-HP altered MHV-68 replication when their expression was inhibited with siRNAs (53% of genes from
Y2H-HP, 21% of genes from Y2H-LP/NS, and 16% of genes randomly chosen from the human PPI network; p,0.05).
Enriched Gene Ontology (GO) terms in the Y2H-HP group included regulation of apoptosis, protein kinase cascade, post-
translational protein modification, transcription from RNA polymerase II promoter, and IkB kinase/NFkB cascade. Functional
validation assays indicated that PCBP1, which interacted with MHV-68 ORF34, may be involved in regulating late virus gene
expression in a manner consistent with the effects of its viral interacting partner. Our study integrated Y2H screening with
multiple functional validation approaches to create c-herpes viral-viral and viral-cellular protein interaction networks.
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Introduction
Gamma-herpesviruses comprise a subfamily of Herpesviridae,a
group of enveloped, double-stranded DNA viruses with large and
complex genomes ranging from 120 to 230 kbp in length [1].
Herpesviruses have two distinct life cycle phases: latency and lytic
replication. During latent infection, no active viral replication
occurs and only a limited number of viral genes, including non-
coding RNAs, membrane proteins, and various nuclear antigens,
are expressed to maintain the viral genome and guard against host
immune responses [2–4]. Upon reactivation of the latent virus,
lytic replication ensues and results in the production of viral
progeny, leading to the destruction of the host cell. In contrast to
alpha and beta herpesviruses, gamma-herpesviruses have distinct
cellular tropisms and establish life-long persistent infections in
lymphocytes [5]. Two well-known human gamma-herpesviruses,
Kaposi’s sarcoma herpesvirus (KSHV) and Epstein Barr Virus
(EBV), are associated with the development of both lymphoid and
non-lymphoid cell tumors, including Kaposi’s sarcoma (KS),
Burkitt’s lymphoma, nasopharyngeal carcinoma, and lymphopro-
liferative diseases in immunocompromised patients [5–8]. Though
tumorigenesis induced by gamma-herpesviruses requires multiple
genes expressed during latent infection, it has been suggested that
lytic viral gene products expressed during sporadic reactivation
in tumor lesions also promote cell growth [4,9,10]. A better
understanding of the interplay between gamma-herpesviruses and
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promoting properties of herpesviruses and may lead to the
development of improved therapeutic strategies.
MHV-68, a natural rodent pathogen, serves as a useful model
for the study of human gamma-herpesviruses due to the similarity
of the gene sequences and genome organization. 80% of MHV-68
ORFs share significant homology with their human viral
counterparts. Furthermore, the ability of MHV-68 to establish
robust de novo productive infections in various human and mouse
cell lines and to infect laboratory mice provides an experimental
system to study the biological significance of virus-host cell
interactions in vitro and in vivo [11–13]. The recent development of
an MHV-68 virus that expresses luciferase provides a powerful
tool to monitor virus replication in live mice [14]. Although it was
known that MHV-68 infected multiple tissue types, live imaging of
viral replication revealed new sites of infection and demonstrated
that timing of lytic replication and clearance varied among
different tissues and organs [14–16]. Combined with the ability to
silence gene expression by RNA interference, and the availability
of transgenic and knockout mice, a wide range of tools are
available to interrogate MHV-68-host interactions both in vitro
and in vivo.
Over the past several years, we have undertaken multiple studies
to systematically characterize the genes and proteins of MHV-68,
beginning with a comprehensive analysis of viral gene expression
[17] and extending to proteomic analysis of the MHV-68 virion
[18], large-scale signature tagged mutagenesis to identify essential
MHV-68 open reading frames [19], and high-throughput random
insertional mutagenesis for genome-scale functional profiling [20].
In this report we characterize the intra-viral and virus-cellular
protein interaction networks of MHV-68. Protein-protein inter-
actions are critical for the functions of most proteins, and the
systematic identification of viral protein interactions will provide
insight into MHV-68 replication and pathogenesis. For example,
viral proteins must interact with each other to create complexes
needed for genome replication and virus assembly. However, even
viruses with large genomes, such as the herpesviruses, require
cellularproteinstosupplyactivitiesnot encoded intheviralgenome.
Viruses also interact with cellular proteins to manipulate cellular
pathways in order to promote an environment favorable to the
virus. Conversely, the cell expresses proteins that may bind directly
to viral proteins to inhibit their functions to promote an antiviral
state.
Although several recent studies have extensively characterized
the intra-viral protein interactions of five herpesviruses [21–25]
much less is known about the gamma-herpesviral-cellular PPI
network. To date, a single experimental study reported 173
interactions between EBV and human proteins [24] and one
computational analysis predicted 20 herpesvirus-cellular protein
interactions [21]. These studies are further limited by the lack of
robust replication of human herpesvirus in vitro and in vivo, which
makes functional validation of virus-cellular interactome difficult.
MHV-68 complements this deficiency and has the capacity for
effective genetic manipulation to study lytic replication in vitro
[19,26]. Thus, a comprehensive inventory of MHV-68 protein
interactions will provide a valuable resource to understand the
interplay between the virus and host cell and will yield insights into
the functions of individual proteins during viral replication.
Therefore, to elucidate the molecular interactions of MHV-68
proteins we conducted genome-wide Y2H screens (Fig. 1). We
report the identification of 23 intra-viral protein interactions and
243 virus-cellular protein interactions, the vast majority of which
are novel. Evaluation of the virus-cellular protein interactions was
aided by the development of a novel scoring method based on the
network distances of MHV-68-interacting cellular proteins within
a high-confidence binary cellular protein interaction network. Our
study integrated computational analysis of MHV-68 interacting
proteins with multiple complementary functional assays to de-
monstrate the biological relevance of the MHV-68 intra-viral and
virus-cellular protein interactomes.
Results
Genome-wide Y2H screens for MHV-68 intra-viral
protein-protein interactions
To systematically investigate the intra-viral PPI networks,
genome-wide Y2H screens with MHV-68 genes were performed
(Fig. 1). All predicted viral ORFs [12] were cloned into a Gateway
entry vector, enabling efficient shuttling of genes into different
expression plasmids. ORFs larger than 1.5 kb were divided into
smaller fragments clones since large genes tend to yield fewer
interactions in the Y2H assay [27]. Similarly, genes encoding
proteins with predicted trans-membrane domains were truncated
to express only the soluble portion. The entire library was then
transferred into the Y2H DNA-binding domain (pDEST32) and
activation domain (pDEST22) destination vectors and transformed
into the yeast strains PJ69-4a and PJ69-4a, respectively [28]. All
possible pair-wise combinations were tested independently for
activation of the reporter genes HIS3 and ADE2 in quadruplicate
using a 384-spot array format. Twenty-five (25) pairs of MHV-68
proteins were found to activate both reporter genes (Fig. 2A,
Table S1), including two pairs in which the partners interacted
when cloned as either bait or prey.
The physical interactions between viral proteins were validated
by co-immunoprecipitation (Co-IP) and co-localization assays
(Table S1; Fig. 2B and C). MHV-68 genes and gene fragments
were transferred to mammalian expression vectors as fusions to the
epitope tags FLAG (pTAG) and V5 (pHB) or the fluorescent
proteins GFP and RFP. HEK293T cells were transfected with
pairs of plasmids encoding putative interacting proteins and
infected with MHV-68 24 h later. Cell lysates were co-immuno-
precipitated with anti-FLAG, anti-V5, or non-specific anti-mouse
Author Summary
Persistent infections by the herpesviruses Epstein Barr
virus (EBV) and Kaposi’s sarcoma herpesvirus (KSHV) are
associated with tumor formation. To better understand
how these and other related viruses interact with their
host cells to promote virus replication and cause disease,
we studied murine gamma-herpesvirus 68 (MHV-68). MHV-
68 belongs to the same group of herpesviruses as EBV and
KSHV, but has the advantage of being able to replicate
efficiently in cell culture. Our study used genome-wide
screens to identify 23 protein-protein interactions between
the 80 MHV-68 proteins. Several of these interactions are
likely to be important for assembling new viruses. We also
discovered 243 interactions between MHV-68 and cellular
proteins. To help prioritize cellular proteins for follow up
studies, we developed a new computational tool to analyze
our data. Proteins with high priority scores were more likely
to affect viral replication than low priority proteins. Among
the cellular proteins that had the greatest effect on MHV-68
replication was PCBP1, which negatively regulated MHV-68
lategene expression. This study identified manynovel cellu-
lar proteins involved in MHV-68 replication and established
a method to identify important proteins from high-
throughput virus-cellular protein-protein interaction data
sets.
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doi:10.1371/journal.ppat.1002297.g001
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and anti-V5 antibodies. Of the 23 intra-viral interactions, 16
(70%) pairs were confirmed in at least one direction of the
antibody pull-down (Table S1, Fig. S1). These interactions were
further validated by co-localization of the interacting partners
using either pairs of GFP- and RFP-tagged or FLAG- and V5-
epitope tagged proteins expressed in NIH 3T3 cells (Table S1).
Three additional interactions could not be confirmed due to the
low expression in our system, but were previously reported
between homologous proteins from other herpesvirus family
members (Table S1) [29–33]. In total, 19 out of 23 interactions
were supported by secondary experiments for a combined
confirmation rate of 83%.
To illuminate the biological roles of the newly identified intra-
viral PPIs, interactions were grouped according to the known and
predicted functions of the viral proteins (viral DNA replication,
assembly/egress, capsid and envelope structural proteins, and
unknown) (Fig. 2A). Tegument proteins were prominently featured
among the interactions detected under our stringent screening
conditions. In particular, ORF45 and ORF33 interacted strongly
in both orientations in the Y2H assay, co-localized in the nucleus
(Fig. 2B), and co-purified in both directions in antibody pull-down
experiments (Fig. 2C). Both are tegument proteins expressed late
during the infection cycle [34,35] and are essential for viral
assembly and egress. Their homologues in KSHV interact with
KSHV ORF64, a hub protein that recruits other tegument
proteins [22]. Our results suggest that the three proteins - ORF33,
ORF45 and ORF64 - may be a part of a larger multi-protein
complex (Fig. S1-B).
To develop a comprehensive view of the current status of
gamma-herpesvirus intra-viral protein interactions, we integrated
the large-scale and literature-curated EBV and KSHV intra-viral
protein interactions from [25] with the MHV-68 interactions
identified here (Fig. S2). Seven non-self MHV-68 interactions were
shared with each gamma-herpes virus, but only two interactions
were found in all three (Table S1). Though many more
interactions have been identified in both EBV and KSHV, the
extent of the overlap between the two is surprisingly small, with
only 13 interactions in common (5% of the 250 non-self
interactions in EBV; 7% of the 175 non-self interactions in
KSHV). The relatively low overlap between EBV and KSHV
appears to be due to different proteins from KSHV and EBV
yielding interactions in the various screens (Fig. S2). Assuming that
interactions between conserved gamma-herpesviruses are con-
served, this suggests that the screens for gamma-herpesvirus intra-
viral interactions have missed many interactions.
Genome-wide Y2H screens for MHV-68-cellular protein-
protein interactions
To identify cellular proteins that interacted with MHV-68
proteins, we performed Y2H library screens with 84 MHV-68
constructs. Since our primary goal in this study was to identify host
factors that played a role in MHV-68 lytic replication, we chose a
high quality cDNA library from a tissue type (human liver) known
to support MHV-68 infection ([36]and unpublished data). MHV-
68 undergoes lytic replication in various human and mouse cell
lines in vitro, including liver-derived cell lines ([11–13], and
unpublished data). In addition, MHV-68 productively infects the
liver in experimentally inoculated mice [14–16]. Finally, liver
tissue contains multiple cell types and expresses a broad range of
cellular genes. We acknowledge that by using a human cDNA
library, interactions with murine-specific proteins will be missed.
Figure 2. The network of interactions between MHV-68 proteins. (A) The MHV-68 intra-viral protein interaction network. Rectangles
designate viral proteins essential for MHV-68 lytic replication; circles, nonessential MHV-68 proteins. Colors indicate protein functions (blue, DNA
replication complex; red, regulatory proteins; orange, envelope proteins; purple, capsid; magenta, assembly or egress; white, unknown function).
Arrows point from baits to preys. Interactions confirmed by co-immunoprecipitation (co-IP) are shown as solid lines, whereas those found only by
Y2H are shown as dashed lines. Green lines indicate novel interactions found in this study; blue lines represent interactions detected between
homologues in other data sets (see Table S1 for references). (B) ORF33 and ORF45 co-localize in the nucleus. Expression plasmids encoding FLAG
epitope-tagged ORF33 and YFP-tagged ORF45 were co-transfected into NIH 3T3 cells. FLAG-ORF33 was detected by IFA with anti-FLAG-M2 primary
antibody and Alexa Fluor 594-conjugated anti-mouse IgG antibodies. Panel 1 shows FLAG epitope-tagged ORF33 (red); panel 2, YFP-ORF45 (green);
panel 3, merged image; panel 4, phase contrast image of same field; panel 5: DAPI-stained nuclei. (C) Co-IP of ORF33 and ORF45. FLAG epitope-
tagged ORF33 and V5 epitope-tagged ORF45 were co-expressed in 293T cells, immunoprecipitated with either control IgG, anti-FLAG M2 or anti-V5
antibodies, and subjected to western blotting with anti-V5 antibody (upper panel) and anti-FLAG (bottom panel). I indicate input.
doi:10.1371/journal.ppat.1002297.g002
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gene fragments are cloned between the GAL4 activation domain
and URA3. (Fig. 1) [37,36]. Growth of yeast on medium lacking
uracil selects for inserts that are cloned in frame and expressed,
and selects against clones whose inserts are in the wrong reading
frame, contain stop codons, or are poorly expressed. Thus, the
library has fewer clones than traditional libraries, which increases
the likelihood of comprehensively sampling the AD clones in Y2H
screens. In addition, frame-shift mutations that occur during Y2H
screening – an important source of false-positives [38] – are
selected against. The 84 MHV-68 genes and gene fragments
described above were cloned into the Gal4 DNA binding domain
plasmid pXDGATcy86 and screened at least twice against the
human liver Y2H library (215 screens total). Seventy-four MHV-
68 genes yielded positive colonies in at least one screen. The
activation domain inserts from 1879 colonies (up to 48 per screen)
were PCR-amplified and sequenced, yielding 1544 pairs of
interacting proteins representing 508 different interactions. All
unique cellular gene fragments (excluding known false-positives)
were then re-cloned into the activation domain plasmid in fresh
yeast cells and retested in the Y2H assay with the bait from the
original Y2H assay. Two hundred-forty three pairs independently
activated expression of both the HIS3 and ADE2 reporter genes in
the retest and were considered true Y2H interactions (Fig. 3A, Fig.
S3, Table S2). Another 25 pairs activated expression of only one
Y2H reporter.
MHV-68 proteins bind to cellular proteins with similar
functions
To characterize the cellular factors identified in the Y2H screen,
we grouped them according to the known or predicted functions of
their viral partners (DNA replication, life-cycle regulation, virion
assembly/egress, and capsid or envelope structural proteins) and
analyzed the functional annotation of all cellular proteins and their
immediate neighbors in the cellular PPI network. Interestingly, the
cellular factors identified in the screen were enriched in Gene
Ontology (GO) terms related to the function of their viral partners
(Fig. S4A). For example, the targets of the viral DNA replication
proteins participated in DNA replication, recombination, and
repair. Similarly, viral regulatory proteins tended to interact with
cellular proteins involved in the regulation of ubiquitin-ligase/
protein kinase activities, protein amino acid phosphorylation, and
the antigen receptor and integrin-mediated signaling pathways,
whereas viral assembly/egress proteins tended to interact with
cellular proteins involved in cell adhesion, lipid homeostasis, and
regulation of cytoskeleton organization/biogenesis (Fig. S4A). GO
terms related to regulation of apoptosis and I-kB kinase/NF-kB
cascade were enriched among the partners of viral proteins in
multiple functional categories (DNA replication, regulation, and
structural) while the regulation of post-translational modification
term was enriched in all the functional groups. This latter
observation may reflect the importance of these modifications at
multiple stages of the viral replication cycle.
Network context of the cellular factors that interacted
with MHV-68 proteins
In order to analyze the network properties of the viral-cellular
protein interactions, cellular proteins identified in the Y2H screens
were mapped onto the nodes of a high-confidence cellular PPI
network. This network consisted of binary interactions reported in
the DIP [39], IntAct [40] and MINT [41] databases that were
supported by at least one small-scale or multiple high-throughput
experiments (see Methods for details). Of the 197 distinct cellular
proteins identified in our screen, 101 were present in this reference
network. The cellular proteins identified in the screen were
connected to an average of 5.7 neighbors, a number significantly
larger than expected by chance (4.1; p-value 1.8610
22). In
addition, the average network distance between two proteins that
interacted with MHV-68 proteins, calculated as the length of the
shortest path connecting the corresponding network vertices, was
Figure 3. The MHV-68-cellular protein interactome. Viral proteins (rectangles) are displayed as a ring and are grouped according to their
functional annotation (colors are as described in legend to Fig. 2). Cellular proteins (circles) that interacted with one viral protein are located outside
of the ring, whereas those that interacted with multiple viral proteins are located inside. Cellular proteins are colored according to the priority rank,
with unranked proteins are shown in white. The size of the circle indicates the magnitude of the effect on MHV-68 lytic replication caused by
inhibiting the expression of the cellular gene by RNAi. Large circles imply greater effect; small circle, no effect or not tested. Font color of the cellular
protein label indicates the direction of the effect on MHV-68 lytic replication (red, inhibiting expression of the cellular gene increased replication, dark
green; inhibiting expression of the cellular gene decreased replication, black, no effect or not tested).
doi:10.1371/journal.ppat.1002297.g003
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reference network (4.6 versus 5.3; p-value 4.0610
24). Similar
trends were also observed with cellular proteins that interacted
with EBV [24] (Table 1). Graphing the distribution of network
distances between proteins targeted by MHV-68 revealed a
significant shift toward smaller values as compared to the
distribution obtained for an equally-sized set of proteins randomly
selected from the reference network (p-value 4.9610
23) (Fig. 4A).
The distribution of the experimental data displayed a sharp drop-
off at the large inter-protein distances and a higher frequency of
proteins three or fewer edges away from each other. These
observations indicate that the cellular factors that interacted with
MHV-68 proteins are located nearer to each other than expected
by chance within the reference PPI network.
In order to rule out the possibility that the observed distribution
arose as a result of biases in the dataset, we performed two additional
analyses. One potential source of bias is the composition of the Y2H
AD library. Since the library was not normalized, highly expressed
genes are likely overrepresented and may give rise to more
interactions, including potential false-positive interactions. We
therefore analyzed how sensitive the distribution of network distances
was to the removal of cellular proteins that interacted with more than
one viral protein. As we observed no significant changes (Fig. S5A) we
infer that, even if present, compositional bias of the cDNA library
does not affect the inter-target distance distribution. A second
potential source of bias is the presence of highly connected proteins
(i.e., those with high degree), which are enriched among the partners
of MHV-68 proteins. Such proteins, by virtue of the large number of
cellular proteins they interact with, have a greater likelihood of being
close to another MHV-68-binding protein by chance. To test this
possibility, we compared the averagedistributionofnetwork distances
between a set of randomly selected proteins with that obtained for an
equivalently sized set of proteins having the same degree distribution
of the cellular proteins that interacted with MHV-68. Although the
distribution of distances in the degree-modified set of random
proteins was shifted slightly toward shorter path lengths (Fig. S5B),
the shift was less than that observed in the experimental data. Also,
the difference between the experimentally observed distance
distribution and the one obtained for the modified reference set
remained statistically significant (p-value 4.8610
22). We therefore
concluded that the distinct shape of the distance distribution
histogram was an inherent property of the set of cellular proteins
specifically targeted by the MHV-68 virus, and was not influenced by
the potential composition bias of the cDNA library used in our screen
or higher than average connectivity of the targeted cellular proteins.
Similar changes in the distance distribution profiles were observed in
previously reported sets of proteins identified in viral-cellular protein
interaction screens (Fig. S6), suggesting that this may be a general
feature of cellular proteins targeted by viruses.
Functional validation of the cellular partners of MHV-68
proteins
Since the shift toward shorter distances between cellular
proteins that interacted with MHV-68 was unlikely to have
Figure 4. Network context of cellular proteins that interacted with MHV-68 proteins. (A) Distribution of the network distances between
cellular proteins that interacted with MHV-68 proteins. The distances between cellular proteins that interacted with MHV-68 proteins in the reference
cellular protein interaction network (i.e., the number of protein-protein interactions that must be passed through to connect a pair of proteins) were
calculated and plotted. Closed circles (thick line) represent the observed distribution of distances between the MHV-68-interacting proteins. Bars (thin
line) show the average distance distribution from an equivalent number of randomly selected cellular proteins. (B) Calculation of a network
neighborhood-based priority score. The black circle indicates a cellular protein that interacted with an MHV-68 protein and that served as the starting
point in this example. Gray circles indicate other human proteins that interacted with MHV-68 proteins. White circles represent human proteins that
did not interact with MHV-68. The priority score was calculated by counting the cellular proteins that interacted with MHV-68 proteins within a
distance of four interactions. (C) The priority scores of the top ranked cellular proteins identified in the Y2H screen.
doi:10.1371/journal.ppat.1002297.g004
Table 1. Network properties of cellular proteins that
interacted with MHV-68 proteins.
Dataset MHV-68
EBV
(Calderwood 2007)
Reference
Network
Distinct Target
Proteins
197 (101*) 113 (65*) 4280
Protein Degree
(p-value)
5.70+/27.36
(1.84610
22)
4.487+/25.60
(2.88610
21)
4.11+/26.48
Network Distance
(p-value)
4.63+/21.13
(4.0610
24)
4.74+/21.24
(1.04610
22)
5.30+/21.47
*Number of proteins found in the reference cellular protein interaction network.
doi:10.1371/journal.ppat.1002297.t001
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linked cellular proteins was important for MHV-68 replication.
We further reasoned that cellular proteins that bound to MHV-68
proteins and that were located in regions of the cellular protein
interaction network with higher densities of MHV-68 targeted
proteins were more likely to play an important role in the MHV-
68 life cycle. To test this hypothesis, we developed a scoring system
to identify such proteins. For each cellular protein that interacted
with an MHV-68 protein, we counted the number of other cellular
proteins that bound to an MHV-68 protein and that were within
four protein-protein interactions in the cellular protein interaction
network (see example in Fig. 4B). The choice of the limiting
distance was based on computational analyses indicating that
functional correlations within PPI networks tend to disappear at
network distances above four [42,43]. Each of the 101 cellular
proteins that interacted with an MHV-68 protein and that were
present in the reference cellular protein interaction network were
scored as described above, with scores ranging from 0 to 81. To
estimate the statistical significance of this score, p-values
corresponding to the probability of having that many neighboring
viral targets were calculated (Fig. 4C, Table S3). We then divided
the proteins into three groups based on their network distance
scores: high-priority (Y2H-HP, which included 60 top ranked
genes), low priority (Y2H-LP, which included the 51 proteins with
the lowest scores), and not scored (Y2H-NS, which included the 96
proteins not present in the reference cellular protein interaction
network).
As a preliminary test to evaluate the biological relevance of
prioritization scores, we inhibited the expression of the 60 highest
scoring cellular genes by RNA interference and analyzed the effect
on MHV-68 replication. A two-step luciferase reporter virus
system was employed to monitor viral replication after siRNA
treatment in a sensitive and medium throughput manner [14,44].
First, siRNA-treated 293T cells were infected with M3-Luc MHV-
68, a reporter virus that contains an M3-promoter driven firefly
luciferase reporter. Second, supernatant from the infected siRNA-
treated cells was used to infect fresh 293T cells and luciferase levels
were measured 20 h later. Because luciferase expression from the
M3-Luc virus has a linear relationship across a broad range of the
infectious particles (Fig. S7A), the level of luciferase activity
provides an indirect measurement of viral titer.
All siRNA experiments were performed in 96-well plates, with
each siRNA being transfected into HEK293T cells in triplicate
wells (Fig. 5A). As negative controls we used an siRNA with a
sequence that did not match any known gene, and siGL3, which
targets luciferase (siGL3 will inhibit luciferase RNA expression in
the first step, but not the second, and has no effect on MHV-68
replication). As a positive control we used siRTA, which inhibited
immediate the MHV-68 early viral gene Replication and
Transcription Activator (RTA) and significantly reduced viral
replication (Fig. 6A). siRNA-transfected cells were infected with a
low titer of the M3-Luc reporter virus (MOI=0.02) that was
empirically determined to enable both positive and negative effects
on virus replication to be detected. The impact of the siRNAs on
cell viability was assessed in parallel by measuring ATP levels at
50 h post-mock infection, which mimics the condition of the cells
at the time of peak virus replication after siRNA treatment
(Fig. 5A). siRNAs that reduced cellular ATP levels more than 40%
were considered to be toxic and were excluded from further
analysis. This experiment was repeated twice with significant
correlation in the magnitude of the fold change in viral replication
(R=0.89). More than 50% of the siRNAs that targeted Y2H-HP
cellular genes either enhanced or inhibited viral replication
(Fig. 5B).
To more rigorously demonstrate the value of this prioritization
scheme, we randomly selected 20 genes each from Y2H-HP, Y2H-
LP, and the set of human proteins from the reference human PPI
network that did not interact with MHV-68 proteins (C-R). Each
gene was inhibited with two independent siRNAs using the
approach outlined above. Genes for which both siRNAs caused
a consistent phenotype, either an enhancement or inhibition of
luciferase levels by at least one log2 relative to the plate median,
were considered to have a significant effect on viral replication
(Fig. 5C, S7B, and S8). Overall, we found 53% of the genes in the
Y2H-HP group significantly affected MHV-68 replication,
whereas only 21% of Y2H-LP and 16% of C-R did so (P,0.05)
(Fig. 5C, S7B, and S8). Thus, consistent with our preliminary
study (Fig. 5B), cellular proteins with high scores were much more
likely to affect MHV-68 replication than cellular proteins with low
scores or that were randomly chosen from the reference network.
These results suggest that the high scoring cellular proteins (i.e.,
those that are located near other cellular proteins that also
interacted with MHV-68 proteins) are among the most critical
cellular targets for the virus, and may reveal regions the virus-
cellular protein interaction network that are more likely to affect
virus replication.
To determine if particular pathways were over-represented
among the Y2H-HP proteins, we repeated the analysis of GO
terms for this subset. As shown in Fig. 5D, five major functional
clusters were significantly enriched (post-translational protein
modification, and regulation of apoptosis, protein kinase cascade,
transcription from RNA polymerase II promoter, and I-kB
kinase/NF-kB cascade). In contrast, the functional annotations
of proteins in the low priority group were mostly involved in
regulating cellular organelle organization and biogenesis, lipid
homeostasis and DNA biogenesis. Moreover, although some
terms, such as regulation of apoptosis, were common to both
groups, they were enriched to a greater extent in the high priority
group. Given that the Y2H-HP proteins were more likely to affect
MHV-68 replication, the fact that these pathways are more highly
enriched in the Y2H-HP group suggests that they may be critical
for MHV-68 replication. It is possible that low priority proteins
may have a more dramatic effect on MHV-68 replication during
the infection in vivo.
PCBP1 and TAX1BP have opposing effects on MHV-68
late gene expression
For more in depth follow up experiments we focused on cellular
proteins that interacted with a group of viral ORFs that were
previously shown to be essential for virus replication in a screen of
MHV-68 signature-tagged mutants [19] and that displayed similar
phenotypes in subsequent mechanistic studies [45–48]. Five viral
proteins (ORF18, ORF24, ORF30, ORF31 and ORF34) were
involved in regulating late gene expression but were dispensable for
early gene expression and DNA replication. In this study we
identified TAX1BP1 (Tax1-binding protein) and PCBP1 (Poly(rC)-
binding protein 1, also referred to as aCPsand hnRNP E)as potential
cellular binding partners of ORF31 and ORF34, respectively. Both
proteins were included in the Y2H-HP group and had a significant
effect on MHV-68 replication when their expression was inhibited.
However, TAX1BP1 and PCBP1 had opposite effects on MHV-68.
Whereas inhibiting TAX1BP1 expression reduced M3-Luc-MHV-
68 replication, silencing PCBP1 caused an increase (Fig. 6A). We
obtained similar results using two additional shRNA constructs
for each gene that targeted different sequences on PCBP1 and
TAX1BP1, confirming our initial observations. Conversely, when
PCBP1 and TAX1BP1 were over-expressed, TAX1BP1 enhanced
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PLoS Pathogens | www.plospathogens.org 7 October 2011 | Volume 7 | Issue 10 | e1002297Figure 5. Functional validation of cellular proteins from the MHV-68-cellular protein interaction network. A) Overview of the functional
validation approach used to evaluate the effect of cellular interacting proteins on MHV-68 replication. HEK293T cells were reverse transfected with
siRNAs targeting cellular genes and infected with M3-Luc MHV-68, which provides a sensitive and conveniently assayed measure of virus replication.
The supernatant was collected at 50 and 58 h post-infection and used to infect fresh 293T cells. Luciferase activity was measured at 20 h post-
infection. (B) The effect of inhibiting expression of cellular proteins from the Y2H-High priority group (Y2H-HP) on MHV-68 replication. Expressiono f
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viral replication approximately 5-fold (Fig. 6B).
The interaction of ORF34 and PCBP1 was analyzed further as
a model to investigate cellular protein effects on viral replication.
We obtained additional support for the physical interaction
between ORF34 with PCBP1 by demonstrating binding in
GST-pull down assays and co-localization in immuno-fluorescence
assays (IFA) in cells (Fig. 7A–C). Since PCBP1 has been shown to
affect gene expression at multiple levels via its cis-binding with
either DNA or RNA [49–51], we hypothesized the interaction of
ORF34 and PCBP1 might regulate viral gene expression. A series
of viral promoter-linked reporter constructs was used to determine
which stage of viral replication was affected by PCBP1. Over-
expressing PCBP1 reduced the induction of the luciferase
expression from two viral late gene promoters (ORF26 and M9
promoters) upon infection (Fig. 7E). In contrast, the inhibitory
effects of PCBP1 were not observed on RTA auto-activation of its
own promoter or on RTA-mediated activation of an MHV-68
early gene promoter (ORF57 promoter) (Fig. 7D). This result was
consistent with the phenotype of the ORF34 knockout mutant
virus, which affected expression of late viral promoter, but did not
affect expression at early viral promoters or reduce viral DNA
replication [48]. Together, these results suggested that the inter-
action of ORF34 and PCBP1 regulates viral replication by
affecting the transcriptional activities of late promoters.
Since the effect of ORF34 on late gene expression is similar to
that of ORF18, ORF24, ORF30 and ORF31, we repeated the
GO term analysis of the cellular proteins that interacted with these
five viral proteins. Three major functional groups were signifi-
cantly enriched, including regulation of transcription activities,
ubiquitination, and post-translational modification. Together,
these results indicate that not only do the viral proteins have
similar roles in the viral life cycle, but they also bind to cellular
proteins with related functions. Furthermore, it suggests an
unexpected role of ubiquitination in the regulation of viral late
gene expression. Future studies will focus on the contributions of
these pathways to MHV-68 late gene expression.
Discussion
We report here the first large-scale interactome analysis of
MHV-68. Using high-throughput Y2H assays, we created MHV-
68 intra-viral and virus-cellular protein interaction networks. In
follow-up experiments we demonstrated the quality of the intra-
viral protein interaction network by confirming the physical
interaction in mammalian cell culture systems. We observed that
the cellular proteins that interacted with MHV-68 proteins tended
to be closer to one another than expected by chance and exploited
this feature to prioritize cellular partners of MHV-68 for in depth
analyses. Through gene knockdown experiments we showed that
Figure 6. PCBP1 and TAX1BP1 have opposing effects on MHV-68 replication. (A) Effect of siRNAs against PCBP1 and TAX1BP1 on MHV-68
replication. Two distinct siRNAs for each gene were tested for their effect on the replication of M3-Luc-MHV-68 as outlined in Fig. 5. Luciferase values
were normalized to the level of replication in cells transfected with the negative control siRNA (siGL3). siRTA is a positive control siRNA against the
viral RTA. (B) Effect of over-expressing PCBP1 and TAX1BP1 on MHV-68 replication. HEK293T cells were transfected with parental vector pHB (vector),
pHB/PCBP1, or pHB/TAX1BP1 and infected with M3-Luc-MHV-68 as in Fig. 5.
doi:10.1371/journal.ppat.1002297.g006
the 60 highest scoring cellular proteins was inhibited using a single siRNA per gene and MHV-68 replication was assessed as described above. The
percentage of siRNAs that enhanced, inhibited, or had no effect on MHV-68 replication is shown. (C) Cellular proteins with high priority scores were
more likely to affect MHV-68 replication. Twenty proteins were randomly selected from the Y2H-HP group, the Y2H-low priority and not scored
groups (Y2H-LP/NS), and the group of cellular proteins not known to interact with MHV-68 proteins (C-R). The expression of each protein was
inhibited with two siRNAs that targeted different regions of the cognate mRNA. MHV-68 replication in the siRNA-transfected cells was measured as
described above. Graph shows the percentage of proteins from each group that caused a statistically significant enhancement or inhibition of MHV-
68 replication. Asterisks indicate the difference between groups was statistically significant (p,0.05). (D) GO term analysis of high scoring cellular
proteins identified in the Y2H screen.
doi:10.1371/journal.ppat.1002297.g005
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cellular factor correlated with the likelihood that the cellular
protein affected MHV-68 replication. By integrating experimental
screening results with systematic data mining, this study presents a
new strategy to analyze and extract biological significance from
virus-cellular protein interaction networks.
The MHV-68 intra-viral protein interaction network
In this study we identified 22 binary interactions between MHV-
68 proteins, including 17 interactions not previously identified in
any other gamma-herpesvirus (Table S1). Though fewer than
reported in other studies [21–24], the interactions appear to be of
high quality as indicated by greater than 70% confirmation rate of
the interactions in co-immunoprecipitation experiments, which
compares favorably to confirmation rates of 42 to 53% in previous
reports [24,23]. The reduced number of interactions is likely due to
the combination of a stringent Y2H strain (PJ69-4) and a pair of
Y2H vectors (pDEST22 and pDEST32) that tend to yield fewer
interactions [52].
Despite the stringent selection conditions in our Y2H screens,
we identified a number of novel intra-viral protein interactions,
several of which involve MHV-68 tegument proteins. Herpesvirus
tegument proteins form a complex matrix located between the
nuclear capsid and viral envelope and participate in viral assembly
and egress [53,54,55]. At the center of this sub-network are
ORF45 and ORF33, which strongly and reproducibly interact
with each other (Fig. S1B). The homologues of ORF45 and
ORF33 were also shown to interact with KSHV ORF64, a hub
protein that recruits other tegument proteins [22]. Our data
suggest that ORF45 may act as a scaffold protein that interacts
with tegument proteins ORF33, ORF52, and ORF67, and with
the envelope protein ORF68, a homologue of EBV major
envelope protein BFLF1 (Fig. S1B). We have previously de-
monstrated that ORF45 is nearly completely absent from the
partially tegumented capsids formed by viruses in which the genes
for either ORF52 or ORF33 were disrupted [35,56] Together,
these results suggest that the recruitment of ORF45 to the capsid
depends on interactions with both ORF52 and ORF33. The
recruitment of ORF45 may further assist the virion assembly by
interacting with tegument protein ORF67 and envelope protein
ORF68. Further studies are needed to determine if interactions
with ORF67 and ORF68 are also required to incorporate ORF45
Figure 7. PCBP1 interacts with ORF34 in mammalian cells and negatively regulates late gene expression. (A) Co-localization of PCBP1
and ORF34 in 3T3 cells. Expression plasmids encoding GFP-tagged PCBP1 and FLAG-tagged ORF34 were co-transfected into NIH 3T3 cells. GFP-PCBP1
was visualized by direct fluorescence. FLAG-ORF34 was detected by immunofluorescence assays with anti-FLAG-M2 antibody and Alexa Fluor 594-
conjugated anti-mouse IgG antibodies. Panel 1 shows GFP-tagged PCBP1 (green); panel 2, FLAG-ORF34 (red); panel 3, merged image; panel 4, phase
contrast image of same field; panel 5, DAPI-stained nuclei. (B) Co-purification of GST-ORF34 and V5 epitope-tagged PCBP1. GST and GST-ORF34 were
expressed in BL21 cells and purified with glutathione beads. Extracts from cells that over-expressed V5-PCBP1 were incubated with either GST or GST-
ORF34 bound beads. Lane 1, input amount of V5-PCBP1; lane 2, GST pull-down of V5-PCBP1; lane 3, GST-ORF34 pull-down of V5-PCBP1. (C) Co-
purification of GST-PCBP1 and FLAG epitope-tagged ORF34. HEK293T cells were transfected with expression plasmids encoding FLAG-ORF34 and
either GST or GST-PCBP1 and then infected with MHV-68. Lysate were incubated with glutathione beads and subjected western blot analysis with
anti-FLAG antibodies. Lanes 1 and 3, input amount of FLAG-ORF34; lanes 2 and 4, GST and GST-PCBP1 pull-down of FLAG-ORF34, respectively. (D)
Over-expression of PCBP1 did not affect expression from early MHV-68 promoters. Reporter constructs encoding the early viral promoters RTA and
ORF57 were co-transfected with parental vector pHB/attR (vector) or pHB/PCBP1 plasmid, with or without the pCMV/RTA plasmid. Luciferase activity
was measured at 24 h post transfection. (E) Over-expression of PCBP1 inhibited expression from late MHV-68 promoters. Reporter constructs
encoding the late viral promoters M9 and ORF26 were co-transfected with parental vector pHB/attR (vector) or pHB/PCBP1 followed by MHV-68
infection at an MOI of 0.5 in 293T cells. Luciferase activity was measured at 24 h post infection.
doi:10.1371/journal.ppat.1002297.g007
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and ORF68.
The MHV-68-cellular protein interaction network
To identify cellular proteins that interacted with MHV-68
proteins, we screened a well-characterized human liver cDNA
library ([36] and unpublished data) and confirmed the initial
positives under stringent selection conditions. MHV-68 undergoes
productive infection in mouse liver in vivo [14–16], and, unlike
human gamma-herpesvirus, replicates robustly in various human
and mouse cell lines in vitro ([11–13], and unpublished data).
Although the liver cDNA library may not include all cellular
proteins that interact with MHV-68, liver tissue contains multiple
cell types and expresses a broad range of cellular genes. In
addition, many more protein-protein interactions have been
reported for human proteins than for mouse proteins, which
enabled the viral-cellular protein interactions to be placed in
the context of the larger cellular protein interaction network.
However, one consequence of using a human cDNA library is that
most interactions identified in this study involved MHV-68
proteins that are conserved in human herpesviruses. More than
half of the interactions that were positive in retest experiments
involved 22 MHV-68 proteins that have homologues in all three
herpesvirus families and more than 90% involved 32 MHV-68
proteins conserved in gamma-herpesviruses. The six non-con-
served MHV68 proteins in our dataset yielded only 20 interactions
(8% of the total). For comparison, 27% of the EBV-cellular protein
interactions involved EBV-specific proteins [24]. Interactions with
murine-specific proteins and proteins important for latency will
require additional studies to be identified.
In total, 243 interactions involving 197 cellular proteins were
identified and confirmed in our Y2H screens and retest ex-
periments. Among the most enriched features of the cellular
proteins revealed by GO enrichment analyses were terms relating
to regulation of apoptosis and regulation of NFkB pathway (Fig.
S6). This observation is consistent with the notion that viruses
encode numerous proteins that counteract cellular immune system
and prevent the host cell from prematurely dying [57–60]. For
example, homologues of the cellular anti-apoptotic protein Bcl-2,
including MHV-68 M11 [61], KSHV ORF16 of [62] and EBV
BHRF1 [63], are found in all gamma-herpesviruses that inhibit
p53-induced apoptosis during infection. Interestingly, one of the
prioritized proteins, the coiled-coil myosin-like BCL2-interacting
protein (BECN1) that interacts with M11, was independently
identified by others to participate in inhibition of apoptosis and
autophagy [64,65]. Another group of proteins, typified by vFLIP
of KSHV and LMP1 of EBV, activate NFkB pathway for cell
survival by inhibiting early lytic viral gene expression and
maintaining viral latency [66–73]. However, as shown in herpes
simplex virus, the regulation of NFkB pathways might have
distinct roles during different stages of viral infection cycles,
promoting replication in the lytic phase and regulating host
immune responses during latency [74]. In addition to being over-
represented in the entire set of interactions, proteins from these
pathways ranked highly on the priority list and significantly
affected virus replication in siRNA based functional assays, sup-
porting the crucial role of these pathways in MHV-68 replication.
To evaluate the functional roles of the MHV-68-interacting
cellular proteins during lytic infection, we used RNA interference
and a luciferase-expressing virus. We focused on lytic replication
because it is required for the production of viral progeny, is more
experimentally accessible than latent infection, and contributes to
viral pathogenesis. Tumorigenesis induced by gamma-herpesvi-
ruses requires multiple genes expressed during latent as well as
lytic replication [10,75,76]. Lytic replication is also directly
involved in the pathogenesis of diseases such as oral hairy
leukoplakia (OHL) caused by EBV and multicentric Castleman
disease (MCD) caused by KSHV. Much remains to be understood
about the process of lytic replication and the roles of cellular
cofactors.
Assay conditions were optimized to reveal both positive and
negative effects on MHV-68 replication. From a set of 40 human
genes that were targeted with two distinct siRNAs, 13 had a
significant effect on virus replication. Of these, six genes caused an
increase in MHV-68 replication when their expression was
inhibited, whereas seven caused a decrease. It is likely the genes
that caused in a decrease in MHV-68 replication when their
expression was inhibited encode proteins that are required for
virus replication and are being exploited by the virus. In contrast,
genes that increased replication when their expression was reduced
may either play a negative regulatory role in the virus life cycle or
may be part of the cellular antiviral defense.
Among the cellular proteins that caused an increase in MHV-68
lytic replication when their expression was inhibited was PCBP1,
which interacted with ORF34. Binding of ORF34 and PCBP1 was
confirmed by affinity pull-down experiments and co-localization in
mammalian cells, suggesting the interaction occurs in vivo. ORF34
was previously implicated in the regulation of late viral gene
expression [48]. Consistent with this phenotype, over-expression of
PCBP1 inhibited expression from late viral promoters, but had no
effect on early viral promoters. Together, the effects of over- and
reduced PCBP1 expression on viral replication and promoter
activity suggest that PCBP1 plays a negative role in the MHV-68
life cycle. PCBP1 is a multi-functional protein that has been
reported to regulate gene expression at the level of transcription,
mRNA splicing, mRNA stability, and translation [77]. Multiple
viruses, including other gamma-herpesviruses, exploit PCBP1 to
regulate of translation, generally in an IRES-dependent manner
[78–83]. Because no known IRES sequences were present in the
promoter constructs, it is unlikely that the effect of PCBP1 on
MHV-68 late promoters was at the level of translation. Similarly,
since both the early and late viral promoter constructs shared a
common 39 UTR and none encoded splice sites, it is unlikely that
PCBP1 altered mRNA stability (which typically occurs through
binding to RNA sequences in the 39 UTR) or splicing of the
reporter gene. Rather, we propose that PCBP1 negatively regu-
lated the transcription of late MHV-68 gene. However, it remains
to be determined whether the inhibitory role of PCBP1 is by
directly binding to the viral DNA or by indirectly modulating
cellular gene expression. Regardless of the exact mechanism, these
results illustrate the potential for the MHV-68-cellular protein
interactome to reveal novel and interesting aspects of virus-cellular
protein interactions.
A network neighborhood approach to prioritize virus-
cellular protein interactions
Network analyses of the MHV-68-cellular protein interactome
indicated that the cellular proteins that bound to MHV-68
proteins tended to be closer to each other in the reference cellular
protein interaction network than expected by chance. We
exploited this observation to develop a method to prioritize the
cellular proteins from the MHV-68-cellular protein interactome
for further characterization. Cellular proteins that interacted with
an MHV-68 protein and that were located near other cellular
proteins that also bound to MHV-68 proteins were given a positive
score, with the magnitude corresponding to the number of MHV-
68-interacting proteins located nearby. In essence, this approach
identified network neighborhoods that contained multiple cellular
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scoring method is not equivalent to the number of cellular binding
proteins (degree) of the MHV-68-interacting proteins. Although
the cellular proteins that interacted with MHV-68 proteins
participated in more intra-cellular interactions than the average
protein in the cellular protein interaction network, the distribution
of network distances between MHV-68 interacting proteins was
only partially dependent on degree. Similarly, the scoring method
is not equivalent to the list of genes bearing enriched GO terms.
Although the highly scoring proteins are enriched in several GO
terms, particularly those related to cell survival and kinase
function, not all proteins with these GO terms received high
scores. Thus, the scoring method provides information not
obtained from standard network or term enrichment analyses.
Proteins from the MHV-68-cellular protein interactome that
scored highly in this scheme were much more likely to affect
MHV-68 lytic replication than proteins with a low score or
proteins randomly chosen from the cellular protein interaction
network that did not interact with MHV-68 proteins (53% vs. 21%
or 16%, respectively). A preliminary screen of the 60 highest
scoring proteins using a single siRNA per gene yielded comparable
results, with slightly more than half the siRNAs causing a
significant change in MHV-68 replication. However, the magni-
tude of the effect on virus replication did not correlate with the
score, though this could be due to differences in the effectiveness of
the siRNAs in reducing expression of the cellular proteins (Fig. S6).
A second caveat is that the scoring system will miss some
important proteins in the MHV-68-cellular protein interactome,
as indicated by the fact that several low or non-scoring also
affected MHV-68 replication. The prioritization approach is also
unable to identify cellular proteins that do not bind to MHV-68
but that affect MHV-68 replication indirectly, unless those
proteins are located in network neighborhoods target by multiple
MHV-68 interactions; genome-wide siRNA screens will be needed
to systematically identify cellular cofactors that indirectly impact
MHV-68.
Since functionally related proteins cluster together in protein
interaction networks [84,85] an implication of our results is that
MHV-68 targets particular cellular processes or pathways through
multiple interactions with viral proteins. Consistent with this
observation, specific GO terms were enriched in this and other
virus-cellular protein interaction networks, which can only occur if
multiple functionally related proteins are present. The fact that
viruses devote valuable resources to interacting with multiple
proteins involved in the same or related functional process suggests
that these pathways or process are particularly important for
successful replication. However, rather than conferring redundan-
cy to the virus, network neighborhoods that have multiple links to
viral proteins appear to represent regions of vulnerability since
inhibiting expression of these cellular proteins was more likely to
affect virus replication. A similar pattern appears to exist among
cellular proteins that bind to HIV-1 proteins [86]. In particular,
MacPherson and collaborators recently reported that known HIV-
1 host factors are functionally and physically linked clusters within
the host cells [86]. Human proteins that interact with HIV-1 can
be grouped in a limited number of functionally and physically
linked clusters within the host cells [86]. Thus, targeting multiple
functionally related proteins may be a general theme in virus-
cellular protein interaction networks.
Comparison of the MHV-68 and EBV-cellular protein
interaction networks
In contrast to the screen for virus-virus protein interactions, our
screen for cellular proteins that interacted with MHV-68 proteins
identified more interactions than a similar study with EBV
proteins (243 versus 173) [24]. Although no interactions between
homologous viral proteins and the same host factor were found, six
cellular proteins were reported in both data sets, which represents
a small but statistically significant overlap (p-value=4.0610
23)
[24]. The high false-negative rates of Y2H screens in addition to
the use of different versions of the Y2H assay, different cDNA
libraries, and different criteria for selecting and confirming true-
positive interactions likely contributed to the low overlap.
However, this should not be taken to imply that MHV-68 and
EBV target completely different sets of cellular proteins, as we
expect that direct comparison in pair wise Y2H or co-purification
experiments would reveal substantial overlap. Furthermore, our
analyses suggest that MHV-68 and EBV target cellular proteins
located in the same region of the cellular protein interaction
network. The average distance between cellular proteins that
interacted with MHV-68 and EBV proteins was significantly
closer than the average distance between an equivalently sized set
of randomly chosen proteins (MHV-68 to EBV vs. random=4.67
vs. 5.31, p-value: 3.0610
25). The same comparisons of the
average distance between cellular proteins that interacted MHV-
68 (or EBV) and influenza virus (Flu) revealed no significant
differences compared to randomly chosen cellular proteins (MHV-
68 to Flu: 4.98; EBV to Flu; 5.05), suggesting that MHV-68 and
EBV target cellular proteins located in the same region of the
cellular protein interaction network and that the network
proximity of the virus-targeted proteins was specific to herpe-
viruses [24,87]. Consistent with this hypothesis, several GO terms,
including regulation of apoptosis, I-kappaB kinase/NFkB cascade,
and ubiquitin-protein ligase activity, were significantly enriched in
both datasets (Fig. S4B). Thus, although the MHV-68 and EBV
data sets are undoubtedly incomplete, that MHV-68 and EBV
appear to be interacting with similar pathways, but utilizing dif-
ferent proteins to do so. An intriguing implication of this hypo-
thesis is that integrating the gamma-herpesvirus-cellular protein
interaction networks may compensate the low coverage of each
screen and may reveal important targets missed when the analyses
are performed with individual data sets. Indeed, merging the
datasets increased the significance of the priority scores of cellular
factors that interacted with either MHV-68 or EBV. This effect was
much stronger for the smaller of the sets (EBV; Table S4) suggesting
the use of composite sets of cellular factors when evaluating newly
identified sets of host factors of related viral species may be a
valuable approach. A similar strategy has been proposed for
evaluating intra-viral protein interaction networks [23].
Conclusions
Individual herpesviruses have co-evolved with their hosts,
adopting diverse strategies to evade the host immune system and
to hijack existing cellular machinery [5,8,88,89]. Our study adds to
the growing list of gamma-herpesvirus protein-protein interactions
and provides additional insight into the complexity of herpesvirus-
host cell interactions. The interactions identified here revealed
cellular genes that significantly impacted MHV-68 replication and
suggest numerous hypotheses about MHV-68pathogenesis that can
be explored in future studies. In addition, we devised a novel
strategy to prioritize cellular binding partners of viral proteins for
in depth analyses. This nontraditional approach enabled rapid
identification of several cellular proteins that negatively or positively
affected MHV-68 replication and provides a valuable method for
extracting biologically relevant interactions from virus-host protein
interaction networks. Finally, this dataset constitutes a valuable
resource for comparative studies of the replication strategies of
gamma-herpesviruses. As herpesviruses encode a core of conserved
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cellular proteins and pathways utilized by multiple herpesviruses
that may serve as new targets for therapeutic intervention.
Materials and Methods
MHV-68 viral ORF library
MHV-68 open reading frames (ORFs) were PCR amplified
from the MHV-68 viral DNA and cloned into pENTR vectors by
using Gateway pENTR/D/TOPO cloning kit (Invitrogen). Total
of 84 MHV-68 ORF pENTR clones, including 64 full length and
14 fragmented viral ORF clones for ORF larger than 1.5 kb, and
6 ORF clones without trans-membrane domain, were generated.
Inserts in entry clones were sequence verified and transferred to
destination vectors for expression in yeast and mammalian system
using Gateway LR Clonase enzyme mix (Invitrogen) suitable for
N-terminus tagging. Destination clones, pTAG and pHB vectors,
were constructed by adding FLAG/Calmodulin Binding Peptide
(CBP) and V5/HIS fusion tag respectively for co-immunoprecip-
itation (Co-IP). pYFP and pRFP vectors were constructed by
adding the genes encoding yellow fluorescent protein and
Discosoma sp. red fluorescent protein (DsRed) respectively for
immunofluorescence assay (IFA) . Recombination of inserts from
pENTR clones results in an in frame fusion at the 39 end of the
fusion epitope tag or fluorescent tag.
Yeast-two-hybrid screens
Strains, plasmids and libraries. Saccharomyces cerevisiae
strains used in this study are listed in Table S5. Yeast were
maintained using standard laboratory procedures [90]. To test for
interactions between viral proteins, MHV-68 ORFs and ORF
fragments were transferred into pDEST22 (GAL4 activation
domain, TRP1) and pDEST32 (GAL4 DNA binding domain,
LEU2) using the Gateway recombination system (Invitrogen) and
transformed into the yeast strains PJ69-4a and PJ69-4a,
respectively. To identify human proteins that interacted with
viral proteins, MHV-68 ORFs and ORF fragments were
recombined into the Gateway vector pXDGATcy86 (GAL4
DNA binding domain, TRP1) [91] and transformed into the
yeast strain R2HMet. Viral DNA binding domain clones were
used to screen a human liver cDNA library generated in plasmid
pOAD.103 (GAL4 activation domain, LEU2, URA3 to select for
fragments cloned in frame with GAL4) [36]. The cDNA library
contained 9.6610
5 independent clones with an average insert size
of 840 bp.
Self-activation test
DNA-binding domain strains were mated to PJ69-4a cells
transformed with the parental activation domain plasmid
pDEST32. Diploid yeast were selected on synthetic drop-out
medium (SD) lacking tryptophan and leucine supplemented with
0.003% adenine (SD–LEU–TRP+ADE) and plated on SD
medium lacking leucine, tryptophan, and histidine (SD–LEU–
TRP–HIS) and containing 0, 1, 3, 5, 10, 20, 50, 75, 100, 125, and
150 mM 3-amino-1,2,4-triazole (3-AT, a competitive inhibitor of
His3). Y2H screens were performed using the lowest concentration
of 3-AT that suppressed yeast growth in the absence of an
interacting activation domain fusion (1 or 3 mM for most DNA-
binding domain constructs).
Y2H screens for interactions between MHV-68 proteins
PJ69-4a cellsexpressingMHV-68activation domainfusionswere
arrayed in 96-spot format on SD–LEU–TRP+ADE medium and
converted to 384-spot format using a Biomek FX robot (Beckman
Coulter, Brea, CA) equipped with 96 pin replicating head; each
strain was represented four times in the 384-spot format. Y2H
assays were performed by replica pinning the activation domain
clones to YPDA (yeast extract-peptone-dextrose plus 0.003%
adenine) medium and then pinning a single DNA-binding-domain
clone on each spot. Diploid yeast containing the DNA-binding
domain and activation domain plasmids were selected on SD–
LEU–TRP+ADE and replica-pinned onto two independent Y2H
selection media: (i) SD–LEU–TRP-HIS supplemented with the
optimal 3-AT concentration as determined above; and (ii) SD–
LEU–TRP2ADE. Yeast growth was assessed after 7 to 14 days at
30 C. Pairs of activation and DNA-binding domain fusions that
stimulated yeast growth on both Y2H selection media in at least
three spots were judged to be true positives.
Y2H library screens
Y2H screens were performed by mating as described by [92]
with the following modifications: Mid log phase R2HMet cells
(1610
7 cfu) containing a pXDGATcy86 clone were mixed with
5610
6 cfu of the human liver activation domain library in YPD
(yeast extract-peptone-dextrose medium), pH 3.5, and incubated
1 h with rotation, at which point the media was replaced with 3 ml
of YPDA, pH 4.5. The cells were collected by centrifugation and
incubated overnight at room temperature to allow mating. Mating
efficiency was estimated by plating an aliquot of each screen on
SD–LEU–TRP+ADE, which selected for diploid yeast containing
both Y2H plasmids; typical yields were 3–5610
5 diploids per
screen. The remaining yeast were collected by centrifugation,
washed once with dH2O, and plated on SD–LEU–TRP-HIS
supplemented with the optimal 3-AT concentration as determined
above. Plates were incubated at 30uC until colonies appeared (4 to
10 days). All DNA-binding domain clones were screened at least
twice. Yeast colonies that grew on SD–LEU–TRP-HIS+3-AT (up
to 48 per screen) were picked and grown overnight in liquid YPDA
medium. The human gene insert in pOAD.103 was then PCR-
amplified with primers 59-CGACGACGAGGATACGCCACC-
GAAC-39, and 59-GAGCTTCGCAGCAACCGGACTAGGA-39
and sequenced from the 59 end with primer 59-ATACGCCACC-
GAACCCTAAGAAA-39. The gene identity was assigned by
querying the human RefSeq database (downloaded 3/4/08) using
Cross Match.
Confirmation of Y2H interactions
PCR products of activation domain inserts from unique
interactions identified in the Y2H library screens were re-cloned
into pOAD.103 by in vivo homologous recombination in the yeast
strain BK100 [93]. Two independent activation domain inserts
were re-cloned for interactions that were identified more than
once in the library screens. Plasmids were verified by PCR and
sequencing. Yeast containing the remade activation domain clones
were spotted on solid SD–LEU–TRP+ADE medium in 96-spot
format with a BioMek FX robot. Each spot was then transferred to
solid SD–LEU–URA+ADE medium in quadruplicate to create a
384-spot array. Strains expressing the DNA-binding domain
fusions were grown to mid log phase in SD–TRP+ADE medium,
collected by centrifugation, resuspended in fresh media and
pinned onto solid YPDA medium in 384-spot format correspond-
ing to the activation domain clone array described above. The
activation domain array was then replica pinned onto the same
plates. After 2 days at 30uC, yeast were replica pinned onto solid
SD–LEU–TRP+ADE medium to select for diploid yeast. Plates
were incubated 3 days at 30uC and the yeast replica pinned
onto three plates: (i) SD–LEU–URA–TRP-HIS containing the
minimum concentration of 3-AT to suppress background growth;
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tion one step above minimum level required to suppress
background growth; and (iii) SD–LEU–URA–TRP–ADE. Plates
were incubated 7 days at 30 C and imaged at days 3 and 7.
Interactions were scored as positive if at least 3 of the 4 spots for
each interaction displayed growth above background growth of in-
plate negative controls on both media lacking HIS and ADE.
Cell lines and antibodies
Human embryonic kidney (HEK)-293T (293T) cells and NIH/
3T3 (3T3) cell lines were both maintained at 37 uC in 5% CO2
atmosphere in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal bovine serum (293T) or bovine calf serum (3T3)
and 1% penicillin and streptomycin. Anti-FLAG-M2 was
purchased from Sigma. Anti-V5, secondary fluorescent antibodies
(Alexa Fluor 594 goat anti-mouse IgG, Alexa Fluor 488 goat anti-
mouse IgG) were purchased from Invitrogen.
Physical and functional validation of the PPIs
Co-immunoprecipitation and affinity pull-down assays.
Co-immunoprecipitation experiments were performed with FLAG
and V5 epitope-tagged proteins. 293T cells at 70–80% confluence
were transfected with plasmids encoding FLAG (pTAG) and V5
(pHB) epitope-tagged cDNAs using Lipofectamine with Plus
reagents (Invitrogen, Carlsbad, CA) according to manufacturer’s
instructions. The cells were infected with MHV-68 (MOI=0.5) at
24 hrs post-transfection and lysed at 18 hrs post-infection with
radiomimmunoprecipitation (RIPA) Buffer (50 mM Tris-HCl
pH 7.4, 0.5% NP-40, 150 mM NaCl, 1 mM EDTA) plus
Complete Protease Inhibitor Cocktail Tablets (Roche). Protein G-
sepharose beads (GE Healthcare) were washed once with RIPA
bufferand incubatedwith 1 mg anti-FLAG(SigmaAldrich), anti-V5
(Invitrogen) or anti-mouse IgG antibodies as negative control (Santa
Cruz Biotechnology) overnight at 4uC. Cell lysates were sonicated,
mixed with antibody-G-sepharose beads in RIPA buffer plus
protease inhibitors for 4 hrs at 4uC with constant shaking. Beads
were washed three times with RIPA buffer and resuspended with
50 ml of SDS-PAGE sample buffer.
For affinity pull-down assay, viral ORFs were transferred into
the Gateway destination plasmid pDEST15 (Invitrogen, Carlsbad,
CA), in which the glutathione S-transferase (GST) gene is fused to
the 59 end of the insert. GST fusion viral proteins were expressed
in E. coli BL21 cells and purified with glutathione agarose beads
(Invitrogen) by standard methods. HEK293T cells were transfect-
ed with cellular cDNA clones (pHB) fused with V5 epitope-tagged
and lysed in RIPA buffer. Cell extracts were incubated with
GST only or GST-Viral ORF-bound beads for 1 h at room
temperature. Beads were washed three times with RIPA buffer
and resuspended with 50 ml of SDS-PAGE sample buffer. The
samples were subjected to SDS-PAGE and western blotting as
described below.
Western blotting
Protein samples were resolved by SDS-PAGE on 12.5% or 15%
polyacrylamide gels and transferred to polyvinylidene fluoride
membrane. Blots were blocked overnight in 5% nonfat dried milk
in phosphate-buffered paline (PBS) with 0.2% Tween 20 (PBST)
and probed with anti-V5 (1:5000) or anti-FLAG-M2 (1:5000)
followed by horseradish peroxidase (HRP) conjugated rabbit anti-
mouse IgG secondary antibody (1:5000) or with HRP conjugated
primary antibody, anti-Flag-HRP (1:5000) and anti-V5-HRP
(1:5000). Blots were imaged using the ECL detection kit (GE
Healthcare) according to manufacturer’s instructions.
Co-localization and immunofluorescence assays
Corresponding FLAG (pTAG), V5 (pHB) tagged, GFP, YPF, or
RFP cDNA expression clones for protein-protein interactions of
interest were co-transfected into 20 million 3T3 cells by using
BioT reagent according to manufacturer’s instructions in 96 wells
plate. At 24–28 hours post-transfection, cells were washed with
100 ml of cold Phosphate-buffered Saline (PBS) and fixed with
50 ml cold methanol on ice for 15 minutes. Fixative was aspirated
and cells were washed with 150 ml cold PBS four times and
blocked with 100 ml blocking buffer (16 PBS, 10% Fetal Bovine
Serum, 1% Bovine Serum Albumin and 0.1% Triton-X 100) for
30 minutes at room temperature. Fifty ml of diluted primary
antibody was added to each well and incubated for one hour at
room temperature. Anti-FLAG-M2 antibodies and anti-V5
antibodies were used for detection of pTAG and pHB expression
clones. Cells were washed with cold PBS four times and incubated
with 50 ml of appropriate fluorescent-conjugated secondary
antibody for another hour. DAPI (Invitrogen, Carlsbad, CA) were
used for nuclease stain for 15 minutes at room temperature.
siRNA knockdown and cDNA over-expression
experiments
Predesigned siRNAs were purchased from Qiagen. The siRNA
sequences were designed by Qiagen using BioPredsi neural-
network based on a large number of siRNA datasets, which has
been shown to have about 70% knockdown efficiency on targeted
transcripts [94–97]. SiGL3 and Negative Control siRNA were
used as controls (Qiagen). Cellular cDNA expression clones were
PCR amplified from revered-transcribed cDNA from 293T and
cloned into Gateway system as previous described. Two pmol of
siRNA or 200 ng of cDNA expression clones (pTAG or pHB)
were reverse-transfected into 293T cells with Lipofectamine 2000
(Invitrogen) according to manufacturer’s instructions in 96 well
format and infected with M3-Luc-MHV-68 at 48 h (siRNA) or
24 h (cDNA) post-transfection. The M3-Luc MHV-68 reporter
virus was constructed by inserting the firefly luciferase gene
downstream of the lytic gene M3 promoter (constructed by Dr.
Seungmin Hwang). Fifty ml of supernatant containing infectious
viral particles from infected cells was carefully transferred to fresh
293T cells 50 h post-infection. Cell extract for luciferase activity
assay was prepared by adding 60 ml of Bright-glo buffer (Promega)
to each well 20 h post-transfer. Transfections were performed in
triplicate and duplicate readings of luciferase activity were
obtained (Molecular Devices). Cytotoxicity assays were performed
on siRNA-transfected cells that were mock-infected at 48 h post-
siRNA transfection. ATP levels were measured at 50 h post-mock
infection with ATPLite Luminescence ATP Detection Assay
System (PerkinElmer) according to the manufacturer’s protocol
for a 96-well microplate.
To be considered for this analysis, we required that the siRNA
treatment resulted in at least 60% of ATP level compare to the
negative controls and that the measurements had less than 30% of
the standard deviation (SD) within the triplicate of each siRNA
treatments. The average signals of the triplicate non-specific
siRNA treatments were similar to the average to the median of
each plate. To avoid plate-to-plate variation, the averages of
luciferase activities of the triplicate measurements were normalized
to the median of all the readings on the same plate which is close
to the average of the negative control. Treatments that increased
the luciferase levels to $the median plus two times the standard
deviation within triplicates of negative controls, which corresponds
to plus one Log2 fold, were considered to have enhanced MHV-68
replication. Similarly, treatments that reduced luciferase levels to
#the median minus two times the standard deviation within
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Log2 fold, were considered to have inhibited virus replication.
Viral promoter assays
Viral promoter reporter plasmids were constructed in which the
firefly luciferase gene was linked to either early (M3 and ORF57)
or late (M9 and ORF26) viral gene promoters. HEK293T cells
were transfected with early viral promoter-firefly luciferase
reporter plasmids with cDNA expression construct (pHB/PCBP1)
or vector alone (pHB/attR) with/without pCMV/RTA co-
transfection. Late viral promoter-firefly luciferase reporter plas-
mids were co-transfected with cDNA expression construct (pHB/
PCBP1) or vector alone (pHB/attR) followed by MHV-68
(MOI:0.5) infection at 24 h post-transfection in 293T cells. A
CMV-driven Renilla luciferase plasmid was co-transfected with
all of the transfection combinations to serve as a control for
transfection efficiency. Cells were lysed with 100 ml Passive Lysis
Buffer (Promega) at 24 h post-transfection for early promoters
assays, and at 24 h post-infection for late viral promoter assays.
Lysates were assayed for firefly and Renilla luciferase activity us-
ing Dual-Luciferase Reporter assay kit (Promega) flowing the
manufacture protocol.
Cellular protein interaction network
The reference protein-protein interaction network was con-
structed by merging binary interactions reported in DIP [39],
IntAct [98] and MINT [99] databases; common curation rules
adopted by these databases within IMEx Consortium [100]
ensure consistent annotation of the experiments and similar level
of quality control. Only direct and physical interactions sup-
ported by at least one small-scale experiment, defined operation-
ally as these reported in a paper describing less than 100
independent experiments were included. Binary, physical inter-
actions inferred from the multi-protein complexes according to
the spoke model (i.e. bait-prey pairs) were included only for
complexes composed of less than 30 proteins. Alternative forms of
the proteins coded by the same gene were merged into one node
within the network. The relatively stringent criteria used here
resulted in a reference human protein-protein interaction net-
work composed of 4280 proteins connected by 8939 interactions.
Whereas of only moderate size when compared to interaction
networks that include the results of large-scale interaction screens
and computational predictions, the reference network constructed
here represents a subset of the currently known human
interactome that is supported by a wide array of independent
experiments reported in more than 3,200 publications. It thus
attempts to minimize experimental and computational bias
possible when constructing interaction sets based predominantly
on the computationally processed results of a small number of
high throughput experiments and computational protein inter-
action predictions.
Distances between two proteins within the reference interaction
network were calculated as the length of the shortest path
connecting the corresponding network vertices with each edge of
the network assigned a weight of 1. Disconnected pairs of proteins
were excluded from the distance analysis.
The distribution of the pair-wise network distances, calculated
as the length of the shortest path between the cellular proteins
identified in the Y2H screen, was constructed by taking into
consideration every protein pair connected within the reference
network described above. It was compared to the distribution of
distances between equivalent numbers of proteins randomly
selected from the reference network. Statistical significance of
the differences in the distribution shape was evaluated by
Monte-Carlo method. To this end distribution of the chi-square
statistic:
x2~
X
dN
(r(dN){ r r(dN))
2
 r r(dN)
,
where r(dN) is the frequency of observing dN distance, was
calculated for 10
4–10
5 random sets of cellular factors and
subsequently to used to estimate p-value as p(C
2.C
2
obs).
Network-based priority score
In order to prioritize cellular factors initially identified in the
Y2H screen, a simple score was calculated by counting, for each
cellular factor, the number of other cellular factors located not
farther than four interactions away within the reference human
protein interaction network (see Fig. 4A). The significance of the
priority scores was estimated by Monte-Carlo method as described
above.
Interaction network and GO terms analysis
All the interactomes were generated by an open sources
plateform for network analysis and visualization software,
Cytoscape (http://cytoscape.org/index.php). GO terms analysis
generated using the BinGO [101] plugin within Cytoscape. The
functional annotations of cellular proteins were analyzed together
with their immediate neighbors in the cellular protein inteaction
reference network under the GO background of Homo Sapiens.G O
terms with specific functional annotation with corrected p- value
less than 1610
23 were selected.
Interaction data deposition
The set of interactions reported in this paper has been sub-
mitted directly to the DIP database and assigned IMEx Consortium
(http://www.imexconsortium.org) IM-15822 accession number.
Supporting Information
Figure S1 Confirmation of MHV-68 intra-viral protein-protein
interactions. (A) Interaction partners from the Y2H screen were
cloned into destination vectors with either a FLAG or V5 epitope
tag and co-transfected into 293T cells. Over-expressed FLAG and
V5 tagged viral protein lysates were immunoprecipitated with
anti-FLAG, anti-V5, or anti-mouse-IgG (negative control) anti-
bodies. Eluates from the co-immunoprecipitations were subjected
to SDS-PAGE and western blotting with anti-FLAG-HRP (upper
panel) and anti-V5-HRP (bottom panel) antibodies. A summary of
results from the co-IP experiments is shown in Table S1. (B)
MHV-68 tegument protein interactions. The colors and shapes of
viral proteins and intra-viral interactions are shown as described in
legend to Fig. 2. Interactions between viral homologues identified
by Rozen et al., 2008 [24] are shown in red.
(EPS)
Figure S2 Combined gamma-herpesvirus intraviral protein
interaction network. Orthologous proteins from MHV-68, EBV,
and KSHV were grouped together and their intra-viral interac-
tions indicated by different colored lines. Interactions between
EBV and KSHV proteins mostly clustered on opposite sides of the
network. Different orthologous proteins from EBV and KSHV
were involved interactions, which accounts for the low number of
interactions that are shared. The most likely explanation is that,
despite their sequence similarity, different subsets of proteins from
EBV and KSHV were functional in the yeast two-hybrid assay.
(EPS)
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Lines indicate protein-protein interactions. Arrows point from
baits to preys. Interactions between cellular proteins are not
shown. Viral proteins are shown as a ring and are color coded
according to their putative functions in the MHV-68 life cycle.
Circles represent nonessential MHV-68 proteins. Rectangles and
circles are colored to indicate protein functions (blue, DNA
replication complex; red, regulatory proteins; orange, envelope
protein; yellow, capsid; magenta, assembly or egress; white,
unknown function). Rectangles designate viral proteins essential
for MHV-68 lytic replication. Cellular proteins are shown as
circles and labeled with their official gene symbol. Cellular
proteins inside the ring of viral proteins interact with more than
one viral protein, whereas those outside the ring interact with a
single MHV-68 protein. Cellular proteins are color-coded
according to their network neighborhood-based priority score.
Green indicates high priority score, yellow indicates low priority
score, and white indicates no priority score. The size of the circle
indicates the magnitude of the effect on MHV-68 lytic replication
caused by inhibiting the expression of the cellular gene by RNAi.
Larger circle implies greater effect; small circle, no effect or not
tested. Font color of the cellular protein label indicates the
direction of the effect on MHV-68 lytic replication (red, inhibiting
expression of the cellular gene increased replication, dark green:
inhibiting expression of the cellular gene decreased replication,
black, no effect or not tested).
(EPS)
Figure S4 Enriched GO terms of cellular proteins that
interacted with MHV-68 or EBV proteins [24]. (A) MHV-68
proteins were categorized according to their putative functions
(replication complex (1), regulation (2), assembly/egress (3), and
unknown). Bar graphs show the 2Log10 (p-value) of the enriched
GO terms of the cellular proteins, plus their immediate neighbors
in reference cellular protein interaction network, that interacted
with the different groups of MHV-68 proteins. Enrichment
analysis was performed using the Cytoscape plugin BINGO. (B)
GO term analysis of MHV-68 and EBV interacting cellular
proteins. GO term enrichment was performed as in part (A).
Terms with a pvalue,1610
23 are shown. The thicknesses of the
line connecting the GO terms to the virus indicates the significance
(2Log10 (p-value)).
(EPS)
Figure S5 Network context of the cellular proteins identified in
genome-wide Y2H screen. (A) The distribution of the network
distances between cellular proteins identified in the Y2H screen
was not affected by the removal of cellular proteins targeted by
more than one viral protein. Solid line, distance distribution for
the complete set of MHV-68-interacting proteins; dashed line,
distance distribution between after removing cellular proteins that
interacted with more than one MHV-68 protein; (B) The
distribution of network distances between proteins randomly
selected from the reference network was not affected by their
degree. Closed circles show the average distance distribution of
randomly chosen sets of cellular proteins; the degree distribution of
this group reflected that found in the reference cellular protein
interaction network. Open circles indicate the average distance
distribution of randomly chosen sets of cellular proteins with a
modified degree distribution that matched with the MHV-68 data
set. Data sets from both cases were equivalent in size the set of
MHV-68-interacting cellular proteins.
(EPS)
Figure S6 Distribution of network distances between cellular
proteins that interacted with EBV proteins. The distances between
cellular proteins that interacted with EBV proteins in the reference
cellular protein interaction network [24] (i.e., the number of
protein-protein interactions that must be passed through to
connect a pair of proteins) were calculated and plotted. Closed
circles (thick line) represent the observed distribution of distances
between the MHV-68-interacting proteins. Bars (thin line) show
the average distance distribution from an equivalent number of
randomly selected cellular proteins.
(EPS)
Figure S7 Effect of inhibiting expression of cellular proteins
from the MHV-68-cellular protein interaction network on MHV-
68 replication. (A) Luciferase activity from cells infected with M3-
Luc-MHV-68 directly correlates with virus titer. Increasing
amounts of M3-Luc-MHV-68 were added to 293T cells and
luciferase activity was assayed from infected cell lysates at 20 h
post infection. The average luciferase value (relative light units) of
triplicate infections is shown and plotted against plaque forming
units determined by plague assays. (B) Summary of the effect of
inhibiting expression of cellular proteins from high priority (Y2H-
HP) and low priority/no score (Y2H-LP/NS) groups on virus
replication (shown in Fig. 5C). The graph show the percentage of
proteins in which from each group that enhanced (white bars),
inhibited (black bars), or had no effect (gray bars) on M3-Luc-
MHV-68 replication.
(EPS)
Figure S8 MHV-68 replication in cells transfected with siRNAs
targeting cellular genes. Twenty proteins were randomly selected
from the high priority (Y2H-HP) group, the low priority/no
score group (Y2H-LP/NS), and the set of cellular proteins (C-R)
not known to interact with MHV-68. Two siRNAs targeting
each gene encoding these proteins were independently transfect-
ed into 293T cells in 96-well plates in triplicate. Replication
of M3-Luc-MHV-68 was then measured as described in Fig. 5
and the Materials and Methods. Graphs show the fold change
(log2 scale) in M3-Luc-MHV-68 replication in siRNA-treated
cells relative to cells treated with a nonspecific siRNA. Data
was normalized to the plate median and negative controls. Box
indicates siRNAs targeting a single gene in which both siRNAs
had a consistent and statistically significant effect on MHV-68
replication (either enhancement or inhibition). Underline indi-
cates siRNAs that reduced cell viability. MHV-68 replication was
not reported for these siRNAs due to the confounding effects of
cellular toxicity.
(EPS)
Table S1 MHV-68 intra-viral protein-protein interactions.
(PDF)
Table S2 MHV-68 virus-cellular protein-protein interactions.
(PDF)
Table S3 Priority rank, priority score, protein degree, and effect
on MHV-68 replication of cellular proteins from the MHV-68-
cellular protein interaction network. The effects of silencing
expression of cellular proteins (Fig. S6C) on MHV-68 replication
were annotated as following: enhanced MHV-68 replication (+),
inhibited MHV-68 replication (2), cellular toxicity (toxic).
(PDF)
Table S4 Priority rank of cellular proteins based on the merged
EBV- [24] and MHV-68-PPI hit list.
(PDF)
Table S5 Yeast strains used in this study.
(PDF)
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